Finch Therapeutics Group, Inc.

FNCH · OTC
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$5-$4-$3-$2
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$1-$1-$1-$4
Other Non-Cash$1$1$0$1
Operating Cash Flow-$5-$4-$4-$5
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0-$1$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$1$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0-$0$0
Net Chg. in Cash-$5-$4-$4-$5
Supplemental Information
Beg. Cash$23$25$29$36
End Cash$18$21$25$31
Free Cash Flow-$5-$4-$4-$5
Finch Therapeutics Group, Inc. (FNCH) Financial Statements & Key Stats | AlphaPilot